Expression and Significance of HER-2/neu and RECK Proteins in Breast Cancer Tissue

被引:0
|
作者
Shen Bo [1 ]
Wei Da [1 ]
Xu Xinyu [1 ]
Zheng Maqing [2 ]
Feng Jifeng [1 ]
机构
[1] Nanjing Med Univ, Dept Internal Oncol, Jiangsu Canc Hosp, Nanjing 210009, Jiangsu, Peoples R China
[2] Nanjing Tech Univ, Sch Pharm, Nanjing 211816, Jiangsu, Peoples R China
来源
JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE | 2013年 / 1卷 / 03期
关键词
Breast carcinoma; HER-2/neu; RECK; Tumor staging; Tumor differentiation;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective: To investigate the expression and clinical significance of HER-2/neu and RECK proteins in breast cancer tissue. Methods: Seventy-six and 30 samples respectively from breast cancer tissue and normal breast tissue were detected by inmunohistochemical SP assay. The expression of HER-2/neu and RECK proteins in breast cancer tissue and normal breast tissue was observed. Besides, the expression intensity and positive rates of HER-2/neu and RECK proteins at different TNM stagings and differentiated degrees of breast cancer tissue were compared, and the relationship between them was analyzed. Results: The positive rate and intensity of HER-2/neu expression were higher, but those of RECK expression were lower in breast cancer tissue than in normal breast tissue. The positive rates and intensity of HER-2/neu and RECK expression were associated with TNM staging and differentiated tumor tissue, and HER-2/neu and RECK expression in breast cancer tissue had a negative correlation. Conclusion: Overexpression of HER-2/neu and reduced and deleted expression of RECK may be one of the biological mechanisms in the occurrence and progression of breast cancer.
引用
收藏
页码:76 / 78
页数:3
相关论文
共 50 条
  • [1] Tissue expression and serum levels of HER-2/neu in patients with breast cancer
    Krainer, M
    Brodowicz, T
    Zeillinger, R
    Wiltschke, C
    Scholten, C
    Seifert, M
    Kubista, E
    Zielinski, CC
    ONCOLOGY, 1997, 54 (06) : 475 - 481
  • [2] Tissue expression and serum levels of HER-2/neu in patients with breast cancer
    Brodowicz, T
    Krainer, M
    Zeillinger, R
    Budinsky, AC
    Wiltschke, C
    Zielinski, CC
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 657 - 657
  • [3] Utility of Serum HER-2/ neu in Prediction of Tissue HER-2 /neu Status of Primary Breast Cancer
    Mokhtari, Maral
    Khosravi, Mohammad Hadi
    MIDDLE EAST JOURNAL OF CANCER, 2021, 12 (04) : 483 - 490
  • [4] Significance of Her-2/neu protein over expression in Indian breast cancer patients
    Vikash Kumar
    Mallika Tewari
    Usha Singh
    H. S. Shukla
    Indian Journal of Surgery, 2007, 69 (4)
  • [5] Her-2/neu and breast cancer
    Kaptain, S
    Tan, LK
    Chen, BY
    DIAGNOSTIC MOLECULAR PATHOLOGY, 2001, 10 (03) : 139 - 152
  • [6] HER-2/neu oncogene expression in advanced breast cancer
    Krogerus, LA
    Leivonen, M
    CANCER DETECTION AND PREVENTION, 2001, 25 (01): : 1 - 7
  • [7] HER-2/neu expression in primary and metastatic breast cancer
    Elyse E. Lower
    Eleanor Glass
    Robbin Blau
    Stacy Harman
    Breast Cancer Research and Treatment, 2009, 113 : 301 - 306
  • [8] HER-2/neu expression in primary and metastatic breast cancer
    Lower, Elyse E.
    Glass, Eleanor
    Blau, Robbin
    Harman, Stacy
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 113 (02) : 301 - 306
  • [9] HER-2/neu diagnostics in breast cancer
    Carney, Walter P.
    Leitzel, Kim
    Ali, Suhail
    Neumann, Rainer
    Lipton, Allan
    BREAST CANCER RESEARCH, 2007, 9 (03)
  • [10] Upregulation of Telomerase Activity by HER-2/neu and Its Significance in Breast Cancer
    Thriveni, Karuvaje
    James, Rani
    Krishnamoorthy, Lakshmi
    Deshmane, Vijayalakxmi
    Bapsy, Padmanabhan
    Ramaswamy, Girija
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2010, 20 (03): : 141 - 147